Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Finance
  • Yacht Buyer
  • Banking
  • Stocks
  • Nyse
  • Loans
ncarol.com

Lineus Medical Expands US Distribution with CoMedical
ncarol.com/10122519

Trending...
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
  • Caraline Skincare's Gentle Glow Cleansing Oil Named Finalist for Best Face Cleanser at the 2026 CertClean Clean Beauty Awards​
SafeBreak Vascular SafeBreak Vascular Installed in a Peripheral IV Lineus Medical
FAYETTEVILLE, Ark. & SEATTLE - ncarol.com -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network with the addition of CoMedical, a vascular access distribution company that services the Pacific Northwest.  CoMedical, founded in 1980 and headquartered in Seattle Washington, is a medical device distributor specializing in the distribution and sale of vascular access products.  CoMedical's sales team consisting of 6 members services Alaska, Idaho, Montana, Oregon and Washington on behalf of Lineus Medical.

"CoMedical is excited to be a partner with Lineus Medical in distributing SafeBreak Vascular in the Pacific Northwest.  We are constantly reviewing the competitive landscape and searching for innovative products that we believe will bring tremendous value to our hospital clients and to their patients.  SafeBreak Vascular fits that mold, and we believe it will improve peripheral IV access  - the life line for many patients.", said Alison Donsky, Principal at CoMedical.

Vance Clement, CEO of Lineus Medical stated, "Launching a new class of medical device is hard work. CoMedical is a well experienced and nationally respected vascular access distribution company with a long history of success.  Having CoMedical represent Lineus Medical and SafeBreak Vascular in the Pacific Northwest creates a win-win opportunity for both our companies. Lineus Medical is excited about the strong customer relationships that CoMedical brings to the table, and CoMedical understands the value of having a new and innovative product in their product portfolio."

More on ncarol.com
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
  • Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
  • Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry

SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging.  When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter.  The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a January 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1

SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required.  Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally.  Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually.

More on ncarol.com
  • Best Book Publishing Company for Aspiring Authors
  • Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • AKG To Demonstrate New Digital E-catalog Experience Daily At CONEXPO CON/AGG 2026
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com.  Follow Lineus Medical on LinkedIn or Twitter.

MKG-0104

1D.I.P.P.E.R Study - Data on file.

2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Jayne Williams Joins Century Fasteners Corp. Sales and Business Development Team
  • Rocket Fibre Services Growing Customer Base With netElastic Networking Software
  • Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
  • 505 Plumbing, Heating & Cooling Launches in Albuquerque, Bringing a Customer-First Approach to Home Services
  • As AI.com Sells For Record $70 Million, Attention Now Turns To ArtificialIntelligence.com
  • AOW Event Sponsored By The Stanglwirt Resort a renowned five-star Austrian wellness destination
  • Average US gambler spends $210 per month in 2026
  • 10X Recruitment Launches Operator-Led Executive Search for Behavioral Health and Legal Leaders
  • Integris Composites developing armor for military in Arctic Circle
  • Caraline Skincare's Gentle Glow Cleansing Oil Named Finalist for Best Face Cleanser at the 2026 CertClean Clean Beauty Awards​
  • Workplace safety ideas from the front lines to highlight Applied Ergonomics Conference in Arlington, Texas
  • OpenSSL Corporation Advisory Committees' Elections 2026: Results Announcement
  • Zarova Vodka Expands Its Ultra-Premium Spirits Portfolio Through Strategic Acquisitions
  • The Legal AI Showdown: Westlaw, Lexis, ChatGPT… or EvenSteven?
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • UK Financial Ltd Sets February 27 CATEX Debut for VENUS Coin, Opening Limited Early Access Through MayaPro Wallet
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Delay In Federal Disaster Assistance Causing Failure Of Small Business In Disaster Areas
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 108
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community - 106
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • Still Using Ice? FrostSkin Reinvents Hydration
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount

Similar on ncarol.com

  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
  • Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute